One tumor sample, PD47450e, harbored a truncating mutation in CDKN2C, which in addition to the loss of the short arm of chromosome 1 would have resulted in biallelic knockout of this important regulator of cell cycle progression. Here, CDKN2C is linked to neoplasm.